A Phase II Window of Opportunity Trial of PRMT5 Inhibitor, GSK3326595, in Early Stage Breast Cancer
Clinical trial NCT04676516 · COMPLETED
Trial details
- NCT number
- NCT04676516
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-08
- Primary completion
- 2022-08-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.